10 stocks we like better than BioMarin Pharmaceutical When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the …
BioMarin Pharmaceutical Inc. (BMRN) on Thursday reported a loss of $16.3 million in its first quarter. The San Rafael, California-based company said it had a loss of 9 cents per share. Earnings, adjusted for stock option expense and non …
Yahoo!11mon
Feb 22 (Reuters) - BioMarin Pharmaceutical Inc ::BIOMARIN ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 GAAP LOSS PER SHARE $0.30.QTRLY TOTAL REVENUES $358.3 MILLION …
* Biomarin says expected annual cost for Brineura to be $486,000 for ultra-rare pediatric brain disease * Biomarin says will have co-pay program to assist with out-of-pocket cost of brineura Source text for Eikon: Further company coverage: …
The stock of San Rafael-based BioMarin Pharmaceutical gained more than 9 percent in value Thursday after a report that Swiss pharmaceutical giant Roche is attempting to acquire it. BioMarin’s stock, which trades on NASDAQ, closed at …
Our proven model does not conclusively show that BioMarin is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to …